Peter Breggin, MD

Peter Breggin, M.D. began the full time private practice of psychiatry in 1968. Dr. Peter Breggin has been informing the professions, media and the public about the potential dangers of drugs, electroshock, psychosurgery, involuntary treatment, and the biological theories of psychiatry for over three decades. Since 1964 Dr. Peter Breggin has been publishing peer-reviewed articles and medical books in his subspecialty of clinical psychopharmacology. He is the author of dozens of scientific articles and more than 20 professional books, many dealing with psychiatric medication, the FDA and drug approval process, the evaluation of clinical trials, and standards of care in psychiatry and related fields.

For thirty years Dr. Breggin has served as a medical expert in many civil and criminal suits including individual malpractice cases and product liability suits against the manufacturers of psychiatric drugs. His work has provided the scientific basis for the original combined Prozac suits, for many tardive dyskinesia cases, and for label changes in many psychiatric drugs.

Dr. Breggin's background includes Harvard College, Case Western Reserve Medical School, a teaching fellowship at Harvard Medical School, a two-year staff appointment to the National Institute of Mental Health (NIMH), and a faculty appointment to the Johns Hopkins University Department of Counseling.

In 1972 Dr. Peter Breggin founded The International Center for the Study of Psychiatry and Psychology (ICSPP) as a nonprofit research and educational network. The Center is concerned with the impact of mental health theory and practices upon individual well-being, personal freedom, and family and community values. He also founded the peer-review journal, Ethical Human Psychology and Psychiatry.